Next 10 |
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Palm Beach, FL – February 10, 2021 – The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. Healthcare physicians are looking for alternate therapies, due to the huge burden of cancer cases and the side e...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...
bluebird bio (NASDAQ: BLUE) is a biotech company that focuses on gene editing. This technology seeks to treat diseases by replacing the defective genes responsible for them with their healthy counterparts. Year to date, shares of Bluebird are down by 33.9%, which is significantly worse than ...
MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American commercial platform, announces that Adele M. Gulfo has joine...
ZURICH and NEENAH, Wis. , June 5, 2019 /PRNewswire/ -- Amcor Finance ( USA ), Inc. (" AFUI ") and Bemis Company, Inc. (" Bemis ") (NYSE: BMS) today announced the extension of the Expiration Time (as defined below) of the offers to exchange by AFUI and Bemis (each, an " Exchange Offer " ...
Merger activity decreased last week with two new deals announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of Total System Services ( TSS ) by Global Payments ( GPN ) for $21.5 billion in an all stock deal. Under the terms of the merger agreement,...
The beginning of every month is exciting for all dividend income investors, as we look back at the previous month and see how much passive dividend income our portfolios generated. No doubt, these are the best posts to write and read online, as it only provides further proof that dividend inve...
NEW YORK , June 3, 2019 /PRNewswire/ -- S&P MidCap 400 constituent Bemis Company Inc. (NYSE: BMS) will replace Mattel Inc. (NASD: MAT) in the S&P 500, and Mattel will replace Bemis in the S&P MidCap 400 effective prior to the open of trading on Friday, June 7 . Amcor Limited ...
News, Short Squeeze, Breakout and More Instantly...
Bemis Company Inc. Company Name:
BMS Stock Symbol:
NYSE Market:
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting PR Newswire Poster to be presented Sunday, December 10, 2023 CAMBRIDGE, Mass. , Dec. 4, 2023 /PRNe...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...